Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of Robotic and Open Approaches to Partial Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: In-Hospital Adverse Outcomes

  • By

  • Quynh Chi Le

  • Mattia Longoni

  • Andrea Marmiroli

  • Fabian Falkenbach

  • Calogero Catanzaro

  • Michele Nicolazzini

  • Federico Polverino

  • Jordan A. Goyal

  • Fred Saad

  • Riccardo Schiavina

  • Luca Fabio Carmignani

  • Alberto Briganti

  • Nicola Longo

  • Markus Graefen

  • Carlotta Palumbo

  • Miriam Traumann

  • Felix K.-H. Chun

  • Pierre I. Karakiewicz

  • November 11, 2025

Share

Objective:

Emphasize the significance of comparing RPCN and OPCN outcomes.

Key Findings:
  • Include statistical significance for clarity.
Interpretation:

Mention clinical implications briefly.

Limitations:
  • Specify how coding inaccuracies might affect results.
Conclusion:

Reiterate the potential impact on clinical practice.

Original Source(s)

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

  • by Quynh Chi Le, Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, Calogero Catanzaro, Michele Nicolazzini, Federico Polverino, Jordan A. Goyal, Fred Saad, Riccardo Schiavina, Luca Fabio Carmignani, Alberto Briganti, Nicola Longo, Markus Graefen, Carlotta Palumbo, Miriam Traumann, Felix K.-H. Chun, Pierre I. Karakiewicz

  • November 11, 2025

Related Content

How HCPs can help students stay healthy at school

"We are at risk as a nation of losing our measles elimination status."

Biomechanical comparison of innovative suture techniques for repair of Achilles tendon rupture in a porcine flexor tendon model

Next-Generation Vascular Surgery: Bridging Expertise and Innovation

Vascular surgery continues to evolve as new endovascular technologies, hybrid procedures and emerging applications of artificial intelligence expand how physicians can approach complex vascular disease.

  • by

  • September 18, 2026

  • 5 min